Key facts
- Abax Health’s last known valuation is $6.5M (Aug 2022).
- It has raised $2.0M; the latest was PE Growth/Expansion in Apr 2025.
- Notable investors include Ansley Capital Group.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Abax Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Abax Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Abax Health
Developer of a clinical analytics and patient communications platform intended to solve healthcare's revenue leakage challenges. The company's cloud-based platform uses data mining and machine learning algorithms to identify when a physician has referred a patient for care but the patient has not received that care, collects the patient's clinical data, connects and educates the patient, and schedules that care, enabling healthcare providers to increase revenue, improve patient relationships and act as a proactive health manager.
- Sector
- Healthcare
- HQ
- Burlington, VT, United States
- Founded
- 2021
- Employees
- 59
- Website
- abaxhealth.com/
- Ownership
- Privately Held (backing)
Abax Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Abax Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Abax Health in its N-PORT filings yet. We sweep new filings monthly.